[{"address1": "11750 Sorrento Valley Road", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "979-446-0027", "website": "https://www.ibioinc.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. The company's vaccines and therapeutics in preclinical development. Its EngageTx\u0099 technology targets bi-specific molecules and its pre-clinical data demonstrates the ability to generate multiple hits creating sequence diversity and promoting Human-Cyno cross reactivity while mitigating cytokine release. The company also has ShieldTx\u0099, a patent-pending antibody masking technology designed to enable specific targeted antibody delivery to diseased tissue without harming healthy tissue. The company was incorporated in 2008 and is headquartered in San Diego, California.", "fullTimeEmployees": 26, "companyOfficers": [{"maxAge": 1, "name": "Dr. Martin B. Brenner D.V.M., Ph.D.", "age": 53, "title": "CEO, Chief Scientific Officer & Director", "yearBorn": 1970, "fiscalYear": 2023, "totalPay": 577311, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Felipe  Duran", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 1072087, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Banjak J.D.", "title": "General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristi  Sarno", "title": "Senior VP of Business Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 10, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 4, "overallRisk": 8, "governanceEpochDate": 1725148800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 1.84, "open": 1.88, "dayLow": 1.8016, "dayHigh": 1.8802, "regularMarketPreviousClose": 1.84, "regularMarketOpen": 1.88, "regularMarketDayLow": 1.8016, "regularMarketDayHigh": 1.8802, "beta": -3.413, "forwardPE": -1.0339549, "volume": 10023, "regularMarketVolume": 10023, "averageVolume": 81912, "averageVolume10days": 48280, "averageDailyVolume10Day": 48280, "bid": 1.8, "ask": 1.86, "bidSize": 1400, "askSize": 1300, "marketCap": 15782197, "fiftyTwoWeekLow": 1.02, "fiftyTwoWeekHigh": 8.6, "priceToSalesTrailing12Months": 315.64395, "fiftyDayAverage": 2.0106, "twoHundredDayAverage": 1.91795, "currency": "USD", "enterpriseValue": 28522564, "floatShares": 6840990, "sharesOutstanding": 8623680, "sharesShort": 79375, "sharesShortPriorMonth": 100926, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0092, "heldPercentInsiders": 0.00198, "heldPercentInstitutions": 0.28424, "shortRatio": 1.09, "shortPercentOfFloat": 0.0092, "bookValue": 2.919, "priceToBook": 0.62696135, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -17129000, "trailingEps": -7.23, "forwardEps": -1.77, "lastSplitFactor": "1:10", "lastSplitDate": 1528675200, "enterpriseToRevenue": 570.451, "enterpriseToEbitda": -1.654, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "IBIO", "underlyingSymbol": "IBIO", "shortName": "iBio, Inc.", "longName": "iBio, Inc.", "firstTradeDateEpochUtc": 1219152600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f0a2faf7-8166-3ef6-9b69-f7e5c346e13d", "gmtOffSetMilliseconds": -14400000, "currentPrice": 1.8301, "targetHighPrice": 5.0, "targetLowPrice": 3.6, "targetMeanPrice": 4.3, "targetMedianPrice": 4.3, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 5302000, "totalCashPerShare": 0.615, "ebitda": -17249000, "totalDebt": 17957000, "quickRatio": 0.906, "currentRatio": 1.687, "totalRevenue": 50000, "debtToEquity": 72.224, "revenuePerShare": 0.026, "returnOnAssets": -0.24051, "returnOnEquity": -0.8108, "freeCashflow": -16602375, "operatingCashflow": -18670000, "grossMargins": 1.0, "operatingMargins": -363.8, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-05"}]